We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Quercetin abrogates chemoresistance in melanoma cells by modulating deltaNp73.
- Authors
Thangasamy, Thilakavathy; Sittadjody, Sivanandane; Mitchell, Geoffrey C; Mendoza, Erin E; Radhakrishnan, Vijayababu M; Limesand, Kirsten H; Burd, Randy
- Abstract
The alkylating agent dacarbazine (DTIC) has been used in the treatment of melanoma for decades, but when used as a monotherapy for cancer only moderate response rates are achieved. Recently, the clinical use of temozolomide (TMZ) has become the more commonly used analog of DTIC-related oral agents because of its greater bioavailability and ability to cross the blood brain barrier. The response rates achieved by TMZ are also unsatisfactory, so there is great interest in identifying compounds that could be used in combination therapy. We have previously demonstrated that the bioflavonoid quercetin (Qct) promoted a p53-mediated response and sensitized melanoma to DTIC. Here we demonstrate that Qct also sensitizes cells to TMZ and propose a mechanism that involves the modulation of a truncated p53 family member, deltaNp73.
- Publication
BMC cancer, 2010, Vol 10, p282
- ISSN
1471-2407
- Publication type
Journal Article
- DOI
10.1186/1471-2407-10-282